152 related articles for article (PubMed ID: 12052755)
1. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
[TBL] [Abstract][Full Text] [Related]
2. Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment.
Ikeguchi M; Ueda T; Fukuda K; Yamaguchi K; Tsujitani S; Kaibara N
Am J Clin Oncol; 2002 Oct; 25(5):454-9. PubMed ID: 12393983
[TBL] [Abstract][Full Text] [Related]
3. Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
Chen JY; Yang H; Wen J; Luo KJ; Liu QW; Lei JY; Zhen YZ; Fu JH
Dis Esophagus; 2016 Oct; 29(7):856-863. PubMed ID: 25873358
[TBL] [Abstract][Full Text] [Related]
4. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
[TBL] [Abstract][Full Text] [Related]
5. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
7. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
8. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
10. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
11. Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status.
Arora S; Mathew R; Mathur M; Chattopadhayay TK; Ralhan R
Pathol Oncol Res; 2001; 7(3):203-8. PubMed ID: 11692147
[TBL] [Abstract][Full Text] [Related]
12. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
13. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
14. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
16. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
18. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
[TBL] [Abstract][Full Text] [Related]
19. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
20. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.
Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS
Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]